ClinicalTrials.govpublic full text
Pharmacogenomic Study for Providing Personalized Strategy to the Treatment of Non-small Cell Lung Cancer (NSCLC) IIIB/IV
non small cell lung cancer, non-small cell lung cancer, excision repair cross-complementing 1, gemcitabine and cisplatin, irinotecan and cisplatin, advanced nsclc, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 891980
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.